Arturo Solis Herrera
USATitle: Treatment Of Diabetic Retinopathy With Medical Enhancement Of The Unsuspected Intrinsic Property Of Melanin To Dissociates The Water Molecule
Abstract:
Diabetic retinopathy is the leading cause of blindness between the ages of 15 and 65 worldwide. The incidence and prevalence have not changed in the last 70 years, which means that the treatments available are not working. diabetic macular edema and proliferative diabetic retinopathy remain the leading causes of both moderate and severe vision loss in most developed countries. In most patients, retinopathy develops 10 to 15 years after diabetes has been diagnosed. Globally, 629 million persons are expected to have diabetes by 2045. The prevalence of diabetes has been increasing in both developing and developed countries. Globally, from 1990 to 2010, visual impairment due to diabetic retinopathy increased by 64% and blindness by 27%. Known risk factors are relatively poor predictors of retinopathy development or progression, and genetic association studies have proved disappointing. Whether diabetic retinopathy begins as a vasculopathy or a neuropathy is not known. So far, treatment of diabetic retinopathy constitutes a formidable challenge.
Biography:
Arturo Solís Herrera, has been Graduated from Institute Polytechnic Nacional, from CDMX, in 1978 as Medicine Doctor, with the specialties including Ophthalmology, in the National University of Mexico, and Neuro-Ophthalmology, at INNN, México. Later on he obtained his Master Science Degree from University of Aguascalientes, México, and thereafter a PhD in Pharmacology, Universidad de Guadalajara, México. Dr. Solís Herrera is director and founder of Human Photosynthesis® Research Center, in Ags., México, in 2007; where he has continued his research until today.